SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-121353
Filing Date
2015-04-07
Accepted
2015-04-07 16:06:01
Documents
5
Period of Report
2015-05-22
Effectiveness Date
2015-04-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d888578ddef14a.htm DEF 14A 420311
2 GRAPHIC g888578g02k50gray.jpg GRAPHIC 14010
3 GRAPHIC g888578g99y44.jpg GRAPHIC 30556
4 GRAPHIC g888578pc_pg1.jpg GRAPHIC 6427
5 GRAPHIC g888578pc_pg2.jpg GRAPHIC 6496
  Complete submission text file 0001193125-15-121353.txt   501180
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36167 | Film No.: 15756404
SIC: 2834 Pharmaceutical Preparations